Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments.


The introduction of biological therapies targeting specific inflammatory mediators revolutionised the treatment of rheumatoid arthritis (RA). Targeting key components of the immune system allows efficient suppression of the pathological inflammatory cascade that leads to RA symptoms and subsequent joint destruction. Reactive amyloid A (AA) amyloidosis, one… (More)

5 Figures and Tables


  • Presentations referencing similar topics